Patents by Inventor Kai Treuner

Kai Treuner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of Neurogenesis By Melatoninergic Agents
    Publication number: 20080167363
    Abstract: The present disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of melatonin or other melatoninergic agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: December 27, 2007
    Publication date: July 10, 2008
    Applicant: BrainCells, Inc
    Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain, Jeff Redwine, Christine Hoffmaster
  • MELANOCORTIN RECEPTOR MEDIATED MODULATION OF NEUROGENESIS
    Publication number: 20080108574
    Abstract: The present disclosure describes compositions and methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a melanocortin receptor (MCR) modulating agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: September 26, 2007
    Publication date: May 8, 2008
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym Lorrain
  • PPAR MEDIATED MODULATION OF NEUROGENESIS
    Publication number: 20080103165
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system including by stimulating or increasing neurogenesis, neuroproliferation, and/or neurodifferentiation. The disclosure includes compositions and methods based on use of a peroxisome proliferator-activated receptor (PPAR) agent, optionally in combination with one or more other neurogenic agents, to stimulate or increase a neurogenic response and/or to treat a disease.
    Type: Application
    Filed: September 18, 2007
    Publication date: May 1, 2008
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym Lorrain
  • HMG CoA REDUCTASE MEDIATED MODULATION OF NEUROGENESIS
    Publication number: 20080103105
    Abstract: The instant disclosure describes methods of treating diseases and conditions of the central and peripheral nervous system including by stimulating or increasing neurogenesis, neuroproliferation, and/or neurodifferentiation. The disclosure includes compositions and methods based on use of an HMGCR modulating agent, optionally in combination with one or more other neurogenic agents, to stimulate or increase a neurogenic response and/or to treat disease.
    Type: Application
    Filed: September 20, 2007
    Publication date: May 1, 2008
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym Lorrain, Jeff Redwine, Christine Hoffmaster
  • COMBINATIONS CONTAINING A 4-ACYLAMINOPYRIDINE DERIVATIVE
    Publication number: 20080064671
    Abstract: The instant disclosure describes compositions and methods for treating diseases and conditions of the central and peripheral nervous system. The disclosure includes compositions and methods based on use of a 4-acylaminopyridine derivative in combination with one or more other neurogenic agents. One 4-acylaminopyridine derivative is MKC-231.
    Type: Application
    Filed: June 21, 2007
    Publication date: March 13, 2008
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
  • 5 HT RECEPTOR MEDIATED NEUROGENESIS
    Publication number: 20070270449
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a 5HTR agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: May 8, 2007
    Publication date: November 22, 2007
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym Lorrain
  • MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS
    Publication number: 20070244143
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of melatonin or other nootropic agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: March 8, 2007
    Publication date: October 18, 2007
    Applicant: BrainCells, Inc
    Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym Lorrain, Dana Gitnick, Jammieson Pires
  • MODULATION OF NEUROGENESIS BY PDE INHIBITION
    Publication number: 20070208029
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a PDE agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: October 20, 2006
    Publication date: September 6, 2007
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd Carter, Kym Lorrain, Jammieson Pires, Kai Treuner
  • GABA RECEPTOR MEDIATED MODULATION OF NEUROGENESIS
    Publication number: 20070112017
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a GABA agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: October 30, 2006
    Publication date: May 17, 2007
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kym Lorrain, Jammieson Pires, Kai Treuner
  • MODULATION OF NEUORGENESIS BY HDac INHIBITION
    Publication number: 20070078083
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on an HDac inhibitory agent alone or in combination with another neurogenic agent to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: September 7, 2006
    Publication date: April 5, 2007
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd Carter, Kym Lorrain, Jammieson Pires, Andrew Morse, Dana Gitnick, Kai Treuner, Alejandro Dearie
  • NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION
    Publication number: 20070049576
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on muscarinic receptor modulation, such as via inhibition of acetylcholine esterase (AChE) activity, alone or in combination with another neurogenic agent to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: August 25, 2006
    Publication date: March 1, 2007
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Tood Carter, Kym Lorrain, Jammieson Pires, Andrew Morse, Dana Gitnick, Kai Treuner, Alex Broadhead
  • Methods for identifying agents and conditions that modulate neurogenesis
    Publication number: 20070015138
    Abstract: Methods and tools for identifying agents and conditions that modulate neurogenesis are disclosed. The disclosure also relates to methods and tools for identifying populations of neural stem cells suitable for transplantation.
    Type: Application
    Filed: July 7, 2006
    Publication date: January 18, 2007
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Jammieson Pires, Kym Lorrain, Todd Carter, Kai Treuner